In the BioHarmony Drug Report Database

"Preview" Icon

Ropeginterferon alfa-2b

Besremi (ropeginterferon alfa-2b) is an unknown pharmaceutical. Ropeginterferon alfa-2b was first approved as Besremi on 2019-02-15. It has been approved in Europe to treat polycythemia vera.

 

Trade Name

 

Besremi
 

Common Name

 

ropeginterferon alfa-2b
 

ChEMBL ID

 

CHEMBL4297819
 

Indication

 

polycythemia vera
 

Drug Class

 

Pegylated compounds

Image (chem structure or protein)

Ropeginterferon alfa-2b structure rendering